China Lays Out Requirements For Biosimilar Extrapolation
Two More COVID Vaccines Also Approved
In what could be a blow to some aspiring developers eyeing the nascent but growing biosimilars market in China, new rules lay out when extrapolation of approved indications of reference biologics will be allowed, meaning this will not be automatic.
